SJM Epic Porcine Valve Trial Signals Turnaround Of St. Jude’s Valve Business
This article was originally published in The Gray Sheet
Executive Summary
St. Jude expects the introduction of its BioCor stented porcine tissue valve in the U.S. later this year to lead a roughly 13% turnaround of the firm's replacement heart valve business in 2003